Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06456463
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-05-31
Brief Title:
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123 Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
Sponsor:
Stemline Therapeutics Inc
Organization:
Stemline Therapeutics Inc
Organization Data
Organization:
Stemline Therapeutics Inc
Class:
OTHER
Study ID:
STML-401-0423
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Stemline Therapeutics Inc
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None